Amendment 379, after Article 40
Union procedures for the authorisation and supervision of medicinal products for human use and rules governing the European Medicines Agency
A9-0141/2024 – Tiemo Wölken – After Article 40 – Am 379
Rejected
- For
- 156
- Against
- 334
- Abstained
- 98
roll-call vote at 19:22 · 27% of votes cast in favour
Roll call requested by The Left
How the groups voted
A group’s line is the position at least two thirds of its voting MEPs took; otherwise it is shown as Divided. Groups from left to right.
| Group | For | Against | Abstained | of | Line |
|---|---|---|---|---|---|
| The Left | 13 | 0 | 0 | 13 | For |
| Greens | 17 | 2 | 6 | 25 | For |
| S&D | 14 | 3 | 40 | 57 | Abstained |
| Renew | 2 | 36 | 0 | 38 | Against |
| EPP | 5 | 74 | 1 | 80 | Against |
| ECR | 1 | 24 | 0 | 25 | Against |
| Patriots | 2 | 22 | 2 | 26 | Against |
| ESN | 0 | 3 | 1 | 4 | Against |
| No group | 1 | 2 | 2 | 5 | — |
“of” = MEPs of the group who voted. Groups as they are now.
Every MEP
4 MEPs of 588 Clear filters
Christine Anderson Germany · ESN
Against
Ivan David Czechia · ESN
Against
Markus Buchheit Germany · ESN
Against
Milan Uhrík Slovakia · ESN
Abstained voted against their group’s line
“Votes in which an MEP voted differently from their group: on decision pages, against a line at least two thirds of the group took; in loyalty figures, against the position most of the group took.” = voted otherwise than a clear line (two thirds of its votes) of the group they sit in now. MEPs with no vote recorded are not listed.